Showing results (31-40 of 127) with videos related to
Sort By:
Pageof 13
Journal of Neurology|December 19, 2025
Serum neurofilament light chain as a biomarker of disease control in multiple sclerosis: a real-world cross-sectional analysis of therapeutic regimensAgni M Konitsioti, Finja Schweitzer, Wibke Johannis, et al.BMC Health Services Research|April 10, 2024
"So at least now I know how to deal with things myself, what I can do if it gets really bad again"-experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative studyAnne Müller, Fabian Hebben, Kim Dillen, et al.Frontiers in Neurology|March 21, 2019
Atypical Autoimmune Encephalitis With Neuropil Antibodies Against a Yet Unknown EpitopeSharmili Edwin Thanarajah, Harald Prüss, Clemens Warnke, et al.Palliative & Supportive Care|April 11, 2023
Cultural adaptation of the Integrated Palliative care Outcome Scale for neurological symptomsKim Dillen, Yasemin Goereci, Veronika Dunkl, et al.Clinical Nuclear Medicine|April 7, 2021
Uncovering an Optic Nerve Sheath Meningioma Using 68Ga-DOTATATE PET/CTSabine Ulrike Vay, Jan-Michael Werner, Christoph Kabbasch, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2013
An assay to quantify species-specific anti-JC virus antibody levels in MS patientsClemens Warnke, Michael Pawlita, Thomas Dehmel, et al.Brain, Behavior, and Immunity|December 15, 2024
Sportizumab - Multimodal progressive exercise over 10 weeks decreases Th17 frequency and CD49d expression on CD8<sup>+</sup> T cells in relapsing-remitting multiple sclerosis: A randomized controlled trialSebastian Proschinger, Sergen Belen, Frederike Adammek, et al.Drug Safety|January 5, 2019
Managing Risks with Immune Therapies in Multiple SclerosisMoritz Förster, Patrick Küry, Orhan Aktas, et al.Journal of Neurology|July 30, 2021
Absolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrestChristoph Adler, Oezguer A Onur, Simon Braumann, et al.Professional Case Management|December 15, 2022
Development of a Long-Term Cross-Sectoral Case and Care Management Manual for Patients With Severe Multiple Sclerosis and Their CaregiversAnne Müller, Kim Dillen, Thomas Dojan, et al.Pageof 13